JPWO2021097009A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021097009A5 JPWO2021097009A5 JP2022527989A JP2022527989A JPWO2021097009A5 JP WO2021097009 A5 JPWO2021097009 A5 JP WO2021097009A5 JP 2022527989 A JP2022527989 A JP 2022527989A JP 2022527989 A JP2022527989 A JP 2022527989A JP WO2021097009 A5 JPWO2021097009 A5 JP WO2021097009A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxy
- pyridin
- dichlorophenyl
- piperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962934407P | 2019-11-12 | 2019-11-12 | |
| US62/934,407 | 2019-11-12 | ||
| PCT/US2020/060108 WO2021097009A1 (en) | 2019-11-12 | 2020-11-12 | Small molecule furin inhibitors for treating infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503852A JP2023503852A (ja) | 2023-02-01 |
| JPWO2021097009A5 true JPWO2021097009A5 (enExample) | 2023-11-20 |
Family
ID=73793799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527989A Pending JP2023503852A (ja) | 2019-11-12 | 2020-11-12 | 感染症を処置するための低分子フーリン阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230011571A1 (enExample) |
| EP (1) | EP4058021A1 (enExample) |
| JP (1) | JP2023503852A (enExample) |
| KR (1) | KR20220104744A (enExample) |
| CN (1) | CN114929220A (enExample) |
| AU (1) | AU2020382819A1 (enExample) |
| CA (1) | CA3157892A1 (enExample) |
| WO (1) | WO2021097009A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019267166C1 (en) | 2018-05-11 | 2023-11-30 | Glaxosmithkline Intellectual Property Development Limited | Furin inhibitors |
| DE102023126563A1 (de) | 2023-09-28 | 2025-04-03 | Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts | Hemmstoffe der Proproteinkonvertase Furin, Verfahren zu deren Herstellung und Verwendung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003037346A1 (en) * | 2001-10-31 | 2003-05-08 | Cell Therapeutics, Inc. | 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer |
| WO2009023306A2 (en) | 2007-05-09 | 2009-02-19 | Burnham Institute For Medical Research | Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
| WO2013138666A1 (en) | 2012-03-16 | 2013-09-19 | Sanford-Burnham Medical Research Institute | Inhibitors of furin and other pro-protein convertases |
| WO2014152716A1 (en) * | 2013-03-15 | 2014-09-25 | President And Fellows Of Harvard College | Substituted heterocyclic compounds for treating or preventing viral infections |
| CN107441094B (zh) * | 2017-08-08 | 2020-05-22 | 南方医科大学 | 尼罗替尼作为治疗登革病毒感染的药物及其制药用途 |
| AU2019267166C1 (en) * | 2018-05-11 | 2023-11-30 | Glaxosmithkline Intellectual Property Development Limited | Furin inhibitors |
-
2020
- 2020-11-12 US US17/776,067 patent/US20230011571A1/en not_active Abandoned
- 2020-11-12 EP EP20823987.1A patent/EP4058021A1/en active Pending
- 2020-11-12 AU AU2020382819A patent/AU2020382819A1/en active Pending
- 2020-11-12 CN CN202080092431.9A patent/CN114929220A/zh active Pending
- 2020-11-12 WO PCT/US2020/060108 patent/WO2021097009A1/en not_active Ceased
- 2020-11-12 KR KR1020227019647A patent/KR20220104744A/ko not_active Ceased
- 2020-11-12 CA CA3157892A patent/CA3157892A1/en active Pending
- 2020-11-12 JP JP2022527989A patent/JP2023503852A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278642B1 (en) | Purine inhibitors | |
| US9649309B2 (en) | Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity | |
| JP7605486B2 (ja) | キナーゼ阻害剤としての置換された縮合複素芳香族二環式化合物およびその使用 | |
| ES2380795T3 (es) | Pirrolopiridinas útiles como inhibidores de proteínas quinasas | |
| NL2000323C2 (nl) | Pyrimidine-derivaten. | |
| JP6655052B2 (ja) | ビヘテロアリール化合物及びその使用 | |
| ES2401192T3 (es) | Deazapurinas útiles como inhibidores de janus cinasas | |
| US10329270B2 (en) | Heteroaryl compounds as BTK inhibitors and uses thereof | |
| ES2637295T3 (es) | Compuestos de 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-ona y su uso como moduladores alostéricos negativos de receptores mGluR2 | |
| JP2019530739A5 (enExample) | ||
| JP7722981B2 (ja) | 医薬化合物 | |
| JP2012525395A5 (enExample) | ||
| EP4534538A2 (en) | Compounds useful as inhibitors of atr kinase | |
| RS54788B1 (sr) | Inhibitori pirimidina pde10 | |
| US20230373935A1 (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
| JPWO2019215341A5 (enExample) | ||
| JPWO2021097009A5 (enExample) | ||
| RU2020140798A (ru) | Ингибиторы фурина | |
| KR20220104744A (ko) | 감염성 질환을 치료하기 위한 소분자 푸린 억제제 | |
| JPWO2021202874A5 (enExample) | ||
| RU2021131710A (ru) | Соединения гексагидро-1h-пиразино[1,2-a]пиразина для лечения аутоиммунного заболевания | |
| HK40107335A (en) | Fgfr inhibitors and methods of use thereof | |
| HK40050074A (en) | Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases | |
| HK40070481A (en) | Fgfr inhibitors and methods of use thereof | |
| HK40070481B (en) | Fgfr inhibitors and methods of use thereof |